Results for
"[search-keyword]"
Sponsor content
201 result(s) found, displaying 31 to 40
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for POLIVY polatuzumab vedotin 30 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VABYSMO faricimab 120 mg/mL solution for injection vial.
-
Prescription medicine registrationActive ingredients: obinutuzumab.
-
Prescription medicine decision summaryTGA decision: Gavreto (pralsetinib) is provisionally approved to treat adults with advanced or metastatic rearranged during transfection- fusion positive thyroid cancer.
-
Prescription medicine registrationActive ingredients: pralsetinib.
-
Prescription medicine registrationActive ingredients: pralsetinib.
-
Prescription medicine registrationActive ingredients: polatuzumab vedotin.
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
Cancellation by sponsorRequested by Roche Products Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Roche Products Pty Ltd - Self-care monitoring web-based application software.